GENFIT (EPA:GNFT) | Finanzwire

PRESS RELEASE

published on 04/24/2025 at 22:10, 9 months 5 days ago

GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate Update
GENFIT reports full-year 2024 financial results and corporate update. Net profit of €1.5 million, Iqirvo® commercial launch in PBC, new ACLF datasets, royalty financing. CEO, Pascal Prigent shares progress and outlook

Financial Results GENFIT ACLF Iqirvo® Full-year 2024
BRIEF

published on 03/10/2025 at 22:15, 10 months 19 days ago

GENFIT's Bondholders Approve Amendments for 2025 OCEANEs Royalty Financing

Bondholders Amendments Royalty Financing GENFIT OCEANEs
PRESS RELEASE

published on 03/10/2025 at 22:10, 10 months 19 days ago

Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs
GENFIT's 2025 OCEANEs bondholders approve amendment of terms & conditions, anticipates Royalty Financing closure. Repurchase & Consent Fee details announced

Repurchase Bondholders Royalty Financing GENFIT 2025 OCEANEs
BRIEF

published on 02/27/2025 at 22:15, 11 months 2 days ago

GENFIT Reports Financial Metrics for 2024

Revenue Growth Cash Position Strategic Partnership Milestone Payment GENFIT Financials 2024
PRESS RELEASE

published on 02/27/2025 at 22:10, 11 months 2 days ago

GENFIT Announces Revenues and Cash Position as of December 31, 2024
GENFIT announces revenues of €67.0 million & cash position of €81.8 million as of Dec 31, 2024, with plans for non-dilutive capital financing deal & upcoming financial communications

Revenues Cash Position Financial Communications GENFIT Non-dilutive Capital Financing
BRIEF

published on 02/14/2025 at 22:15, 11 months 15 days ago

GENFIT revises the conditions of its offer for the 2025 OCEANEs

General Meeting Royalty Financing Bond Buyback GENFIT OCEANEs 2025
PRESS RELEASE

published on 02/14/2025 at 22:10, 11 months 15 days ago

GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders
GENFIT announces amendment of final terms of dual proposal to 2025 OCEANEs holders, seeking consent for repurchase at EUR 32.75 per bond or a consent fee of EUR 0.90 per bond still outstanding

Repurchase Amendment GENFIT Consent Fee 2025 OCEANEs
BRIEF

published on 02/10/2025 at 07:35, 11 months 20 days ago

GENFIT Proposes Terms for 2025 OCEANEs Bondholders

Royalty Financing GENFIT Bond Repurchase Financial Terms 2025 OCEANEs
PRESS RELEASE

published on 02/10/2025 at 07:30, 11 months 20 days ago

GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders
GENFIT announces final terms for dual proposal to the 2025 OCEANEs holders, offering to repurchase bonds at EUR 32.00 or pay a consent fee of EUR 0.60 per bond. Proposals subject to bondholders' approval and closing of royalty financing

Repurchase Royalty Financing GENFIT Consent Fee 2025 OCEANEs
BRIEF

published on 02/06/2025 at 22:15, 11 months 23 days ago

GENFIT unveils its future clinical trials and expectations for 2025

Clinical Trials Biopharmaceutical 2025 GENFIT ACLF

Published on 01/30/2026 at 14:00, 5 hours 35 minutes ago

CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 11 hours ago

Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 11 hours 35 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 17 hours 20 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 19 hours 35 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies

View all ACCESSWIRE

Published on 01/30/2026 at 19:13, 22 minutes ago

Total Voting Rights
Published on 01/30/2026 at 18:31, 1 hour 3 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/30/2026 at 18:30, 1 hour 4 minutes ago

HOL-Holdings in Company
Published on 01/30/2026 at 18:23, 1 hour 11 minutes ago

TVR-Total Voting Rights
Published on 01/30/2026 at 18:17, 1 hour 17 minutes ago

POS-Transaction in Own Shares

View all EQS

Published on 01/30/2026 at 17:45, 1 hour 50 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 08:00, 11 hours 35 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 1 day 1 hour ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 1 hour ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 1 hour ago

Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE

News